加载中
HKSEHealthcareMedical - Care Facilities
最新数据
HK$0.755
−HK$0.005 · -0.66%
Operating as an investment holding company, Human Health Holdings Limited delivers a comprehensive range of healthcare services across Hong Kong. Its primary care offerings encompass a wide array of services such as routine consultations, diagnostic testing, preventive health programs, minor medical interventions, immunizations, comprehensive physical examinations, health education, and occupational health guidance. Additionally, they provide Traditional Chinese Medicine, work injury assessments, telemedicine, COVID-19 specific services, community outreach, and various health-related products and solutions. The company extends its expertise to numerous specialized medical fields, including general surgery, orthopedics and traumatology, ophthalmology, otorhinolaryngology, pediatrics, obstetrics and gynecology, gastroenterology and hepatology, respiratory medicine, cardiology, pediatric surgery, dermatology and venereology, psychiatry, radiology, urology, nephrology, neurosurgery, anaesthesiology, and oncology. Complementing these are allied health services like physiotherapy, clinical psychology, medical aesthetics, nutritional counseling, health and wellness programs, endoscopy, and advanced medical diagnostics. Furthermore, a full spectrum of dental care is available, ranging from general dentistry, dental implants (including 3D guided surgery), crowns, bridges, and periodontal treatments, to prosthodontics, oral surgery, orthodontics, and endodontics. Cosmetic options like teeth whitening, veneers, and laser dentistry are also provided, alongside advanced oral and maxillofacial surgery, CAD/CAM technology, panoramic radiography, and cone-beam CT scans. Beyond direct patient care, the company manages agreements for healthcare practitioners and offers essential medical imaging services. Established in 1997 and headquartered in Kowloon, Hong Kong, Human Health Holdings Limited maintained a network of 58 medical centers and 103 service points as of June 30, 2021. It operates as a subsidiary of Treasure Group Global Limited.
最新数据
HK$0.755
−HK$0.005 · -0.66%
盘中时间采用HKT。市场数据可能有所延迟。
Operating as an investment holding company, Human Health Holdings Limited delivers a comprehensive range of healthcare services across Hong Kong. Its primary care offerings encompass a wide array of services such as routine consultations, diagnostic testing, preventive health programs, minor medical interventions, immunizations, comprehensive physical examinations, health education, and occupational health guidance. Additionally, they provide Traditional Chinese Medicine, work injury assessments, telemedicine, COVID-19 specific services, community outreach, and various health-related products and solutions. The company extends its expertise to numerous specialized medical fields, including general surgery, orthopedics and traumatology, ophthalmology, otorhinolaryngology, pediatrics, obstetrics and gynecology, gastroenterology and hepatology, respiratory medicine, cardiology, pediatric surgery, dermatology and venereology, psychiatry, radiology, urology, nephrology, neurosurgery, anaesthesiology, and oncology. Complementing these are allied health services like physiotherapy, clinical psychology, medical aesthetics, nutritional counseling, health and wellness programs, endoscopy, and advanced medical diagnostics. Furthermore, a full spectrum of dental care is available, ranging from general dentistry, dental implants (including 3D guided surgery), crowns, bridges, and periodontal treatments, to prosthodontics, oral surgery, orthodontics, and endodontics. Cosmetic options like teeth whitening, veneers, and laser dentistry are also provided, alongside advanced oral and maxillofacial surgery, CAD/CAM technology, panoramic radiography, and cone-beam CT scans. Beyond direct patient care, the company manages agreements for healthcare practitioners and offers essential medical imaging services. Established in 1997 and headquartered in Kowloon, Hong Kong, Human Health Holdings Limited maintained a network of 58 medical centers and 103 service points as of June 30, 2021. It operates as a subsidiary of Treasure Group Global Limited.
日内区间
当前HK$0.755
52周区间
当前HK$0.755
盘中时间采用HKT。市场数据可能有所延迟。
Operating as an investment holding company, Human Health Holdings Limited delivers a comprehensive range of healthcare services across Hong Kong. Its primary care offerings encompass a wide array of services such as routine consultations, diagnostic testing, preventive health programs, minor medical interventions, immunizations, comprehensive physical examinations, health education, and occupational health guidance. Additionally, they provide Traditional Chinese Medicine, work injury assessments, telemedicine, COVID-19 specific services, community outreach, and various health-related products and solutions. The company extends its expertise to numerous specialized medical fields, including general surgery, orthopedics and traumatology, ophthalmology, otorhinolaryngology, pediatrics, obstetrics and gynecology, gastroenterology and hepatology, respiratory medicine, cardiology, pediatric surgery, dermatology and venereology, psychiatry, radiology, urology, nephrology, neurosurgery, anaesthesiology, and oncology. Complementing these are allied health services like physiotherapy, clinical psychology, medical aesthetics, nutritional counseling, health and wellness programs, endoscopy, and advanced medical diagnostics. Furthermore, a full spectrum of dental care is available, ranging from general dentistry, dental implants (including 3D guided surgery), crowns, bridges, and periodontal treatments, to prosthodontics, oral surgery, orthodontics, and endodontics. Cosmetic options like teeth whitening, veneers, and laser dentistry are also provided, alongside advanced oral and maxillofacial surgery, CAD/CAM technology, panoramic radiography, and cone-beam CT scans. Beyond direct patient care, the company manages agreements for healthcare practitioners and offers essential medical imaging services. Established in 1997 and headquartered in Kowloon, Hong Kong, Human Health Holdings Limited maintained a network of 58 medical centers and 103 service points as of June 30, 2021. It operates as a subsidiary of Treasure Group Global Limited.
日内区间
当前HK$0.755
52周区间
当前HK$0.755
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（HKD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 6.72亿 HKD | 6.44亿 HKD | 5.91亿 HKD | 10.02亿 HKD | 11.22亿 HKD |
| 销货成本 | 3.6亿 HKD | 3.48亿 HKD | 3.21亿 HKD | 4.09亿 HKD | 4.62亿 HKD |
| 毛利 | 3.11亿 HKD | 2.97亿 HKD | 2.7亿 HKD | 5.93亿 HKD | 6.6亿 HKD |
| 销售、一般及管理费用 | 2.05亿 HKD | 1.97亿 HKD | 1.84亿 HKD | 2.11亿 HKD | 1.68亿 HKD |
| 营业费用 | 2.05亿 HKD | 1.97亿 HKD | 1.84亿 HKD | 2.11亿 HKD | 1.68亿 HKD |
| 利息收入 | 790.1万 HKD | 1270.2万 HKD | 1715.2万 HKD | 849.1万 HKD | 19.9万 HKD |
| 利息支出 | 649.9万 HKD | 655万 HKD | 822万 HKD | 829.7万 HKD | 293.4万 HKD |
| 折旧和摊销 | 6690.3万 HKD | 6770.6万 HKD | 6800.9万 HKD | 7479万 HKD | 6307.4万 HKD |
| 营业利润 | 1.06亿 HKD | 9910.6万 HKD | 1794.3万 HKD | 3.07亿 HKD | 4.29亿 HKD |
| 净利润 | 2712.7万 HKD | 2633.6万 HKD | 2418.9万 HKD | 1.81亿 HKD | 3.75亿 HKD |
公司数据更新于 2026年10月16日。
近期已公布业绩
近期已公布业绩
年度分割调整后的每股现金分配。
HK$0.03
2025年（完整年度）-75.0% 自从 2021
HK$0.12
2,021
HK$0.30
2,022
HK$0.16
2,023
HK$0.028
2,024
HK$0.03
2,025
| 行动 | 除息日 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股息即将实施 | 2026年12月11日 | HK$0.031Annual | 2026年12月15日 | 2027年1月5日 |
股息 | 2025年12月15日 | HK$0.03Annual | 2025年12月17日 | 2026年1月5日 |
股息 | 2024年12月4日 | HK$0.028Annual | 2024年12月6日 | 2024年12月30日 |
股息 | 2023年12月11日 | HK$0.16Annual | 2023年12月12日 | 2023年12月29日 |
股息 | 2022年12月6日 | HK$0.30Annual | 2022年12月7日 | 2022年12月23日 |
股息 | 2021年12月7日 | HK$0.12Annual | 2021年12月8日 | 2021年12月28日 |
除息 2026年12月11日
HK$0.031
Annual
2026年12月15日登记 · 支付日 2027年1月5日
除息 2025年12月15日
HK$0.03
Annual
2025年12月17日登记 · 支付日 2026年1月5日
除息 2024年12月4日
HK$0.028
Annual
2024年12月6日登记 · 支付日 2024年12月30日
除息 2023年12月11日
HK$0.16
Annual
2023年12月12日登记 · 支付日 2023年12月29日
除息 2022年12月6日
HK$0.30
Annual
2022年12月7日登记 · 支付日 2022年12月23日
除息 2021年12月7日
HK$0.12
Annual
2021年12月8日登记 · 支付日 2021年12月28日
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
